CO-DIAGNOSTICS, INC. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8f7c02bd-0c3b-4391-a24d-5e1d9dcf0184/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $622.5k | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-014158 |
| FY 2024 | $3.9M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000932 |
| FY 2023 | $6.8M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-009955 |
| FY 2022 | $34.2M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-007925 |
| FY 2021 | $97.9M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007662 |
| FY 2020 | $74.6M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006810 |
| FY 2019 | $215.0k | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-005305 |
| FY 2018 | $39.9k | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004300 |
| FY 2017 | $7.7k | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-004300 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CO-DIAGNOSTICS, INC. — all facts · Net Income · Operating Income